NPRA Approves Malaysia’s First RSV Vaccine, Protecting Both Infants and Older Adults
The National Pharmaceutical Regulatory Agency (NPRA) has officially approved ABRYSVO®, Malaysia’s first Respiratory Syncytial Virus (RSV) vaccine. It’s designed for two of the most vulnerable groups: Pregnant individuals (to protect…